Carmel Capital Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $2.3M | Sell |
|
|||||
|
2024
Q3 | $3.54M | Sell |
|
|||||
|
2024
Q2 | $3.36M | Sell |
|
|||||
|
2024
Q1 | $3.87M | Buy |
|
|||||
|
2023
Q4 | $2.01M | Sell |
|
|||||
|
2023
Q3 | $1.69M | Sell |
|
|||||
|
2023
Q2 | $1.96M | Buy |
|
|||||
|
2023
Q1 | $1.74M | Buy |
|
|||||
|
2022
Q4 | $1.77M | Buy |
|
|||||
|
2022
Q3 | $1.48M | Buy |
|
|||||
|
2022
Q2 | $1.33M | Sell |
|
|||||
|
2022
Q1 | $2.49M | Buy |
|
|||||
|
2021
Q4 | $2.99M | Buy |
|